Page 81 of Pharma and Healthcare

Lupin, Lupin Limited, generic formulations, sleep disorders, healthcare news,

USFDA gives tentative approval to Lupin’s prostate cancer tablets

This product will be manufactured at Lupin’s Pithampur facility in India.

October 17, 2023 11:22 IST

Sun Pharma, Philogen, Melanoma, Skin cancer, healthcare news, pharma news,

Sun Pharma and Philogen’s melanoma drug shows promising outcome in Phase 3 trial

On May 30, 2023, Philogen and Sun Pharma entered into a distribution, license, and supply agreement for commercializing Nidlegy in…

October 16, 2023 17:20 IST

OPPI, OPPI news, OPPI appointments, healthcare news, pharma news,

OPPI appoints Anil Matai as Director-General

After superannuating as Managing Director of Zydus Healthcare Ltd, Anil was engaged as Senior Advisor – Life Sciences at IQVIA…

October 16, 2023 16:59 IST

Long Covid, Long cold, Long cold, long cold in UK, influenza, healthcare news,

What is ‘Long Cold’? Read on to know all about this effect with long-lasting symptoms

The team found that long COVID were more likely to have reduced taste or smell and weakness.

October 16, 2023 16:41 IST

Black death, smallpox & syphilis, ancient DNA, human history, paleomicrobiology

From ‘Black Death’ to smallpox, how ancient DNA discoveries are rewriting human history

Smallpox is also getting new date of existence. Until recently, scientific proofs showed that existence of smallpox was confirmed with…

Updated: October 16, 2023 16:00 IST

Sleep Apnea, Sleep Apnea in India, Sleep disorders, sleep cycle, healthcare news,

104 million Indians may suffer from Obstructive Sleep Apnea; Here’s what you need to know

There are many symptoms of sleep apnea such as snoring, fatigue, day-time sleepiness, mood swings, lack of focus and so…

October 16, 2023 15:01 IST

Cancer, cancer drugs, chemotherapy, chemotherapy drugs, cancer treatment, healthcare news, cancer news, pharma news,

Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines

Executing its expansion plans in the ASEAN region, the company’s oncology wing has also secured marketing approval from Myanmar for…

October 16, 2023 13:05 IST

Anaesthesia, world anaesthesia day, medical, surgery, global healthcare community, global healthcare, healthcare community, october, pharma and health, healthcare news

World Anaesthesia Day 2023: Know the date, history, theme, and significance

The World Federation of Societies of Anaesthesiologists established the World Anaesthesia Day

October 16, 2023 12:59 IST

Gynophobia, science, science news, africa, east africa, psychological condition, psychology, world, world news

What is gynophobia? Here’s why a 71-year-old man lock himself for 55 years

Rwandan man, 71, isolated 55 years fearing women (Gynophobia). Compassionate neighbors provide essentials from distance

October 14, 2023 17:30 IST

Ozempic’s impact on kidney patients limited, Dialysis Provider DaVita says

Wells Fargo analysts said the market was overreacting to Novo’s study and that they see GLP-1 drugs as having a…

October 13, 2023 15:25 IST

Pregnancy, Pregnancy termination, abortion, women's health, healthcare news, supreme court on 26 week pregnancy

Pregnancy termination case: Supreme Court demands report from AIIMS medical board on condition of foetus

Under the Medical Termination of Pregnancy (MTP) Act, the upper limit for the termination of pregnancy is 24 weeks for…

October 13, 2023 14:02 IST

USFDA gives tentative approval to Lupin’s generic formulation to treat excessive daytime sleepiness

Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch, the company stated.

October 13, 2023 12:50 IST

Sun Pharma, Eye diseases, Eye disorder, dry eyes, trial results, healthcare news, pharma news,

Sun Pharma’s eye drug shows promising results in Phase 4 trial

CEQUA was generally well tolerated in the study, consistent with its established safety profile, and there were no new safety…

October 13, 2023 12:25 IST

Eli Lilly, Eli Lilly drug trial, Crohn's disease, healthcare news, pharma news,

Eli Lilly’s Crohn’s disease drug succeeds in late-stage study

Crohn’s Disease is a chronic bowel disease that causes inflammation in the digestive tract, and can lead to diarrhea, abdominal…

October 13, 2023 11:05 IST

Novo Nordisk, weight loss drugs, Ozempic, Wegovy, healthcare news, pharma news,

Novo Nordisk warns consumers of surge in its fake weight loss drugs Ozempic, Wegovy

Amid a global obesity crisis, Novo became Europe’s most valuable company last month on soaring profits for Wegovy and Ozempic.

October 12, 2023 16:55 IST

Vaping, Vaping benefits, Vaping side effects, health news, wellness news,

Group working to curb vaping addiction seeks support from women parliamentarians

Vaping devices have evolved with attractive designs and various flavours ranging from strawberry to bubble gum, making them highly popular…

October 12, 2023 16:43 IST

eye disease, world sight day, eyesight, eye redness, world sight day 2023

World Sight Day 2023: How to protect your vision from ‘dry eye syndrome’ – Easy Tips

According to a recent study, approximately 60% of people who work in urban office environments experience DES.

Updated: October 12, 2023 16:36 IST

Ozempic, Wegovy, Novo Nordisk, healthcare news, pharma news,

Novo drugs Ozempic and Wegovy are shaking up stock markets again

As investors bet that this new class of weight-loss drugs will improve the overall health of millions of Americans, US…

October 12, 2023 16:21 IST

Related News

According to Legg, the disruption will be uneven across industries.

AI will end work-from-home, says Google DeepMind Co-Founder Shane Legg

Delhi makes two key GRAP-4 rules permanent to combat ‘severe’ pollution – All you need to know

Indian Govt urges vehicle owners, DL holders to update mobile number on Vahan, Sarathi portals: Here’s how

Hidden Gems: The electrification play inside this company’s portfolio.

The ‘Birla’ lineage small-cap quietly powering India’s electronics boom

Karti Chidambaram, Karti Chidambaram Infosys, Infosys land sale, Infosys Puravankara deal, Infosys Bengaluru land sale, Infosys Anekal land, Infosys Attibele Hobli land, ₹250 crore land deal, Puravankara Infosys land, Puravankara Bengaluru expansion, Karnataka land allotment controversy, concession land sale Karnataka, Infosys land controversy, Congress MP on Infosys deal, Karnataka Development Index post, Puravankara land bank, Puravankara GDV ₹14,000 crore, Puravankara expansion plan, Ashish Puravankara statement, Mallanna Salasu Puravankara, Bengaluru real estate news, Karnataka political news, corporate land sale India, IT company land deal, Bengaluru property market news

‘Bengaluru land was not govt-allotted’: Infosys denies Karti Chidambaram’s claims over Attibele land deal

L&T wins order worth nearly Rs 1,000-2,500 cr for Hyderabad Greenfield project

Industry23 min ago

Larsen & Toubro’s Transportation Infrastructure business has won a significant order worth Rs 1,000-2,500 crore for the Hyderabad Greenfield Radial Road project. This 22.3 km long road will improve regional connectivity and link Hyderabad’s Outer Ring Road with the upcoming Regional Ring Road.

View all shorts